Novan (NOVN) moves, what does this mean for the stock & can it go beyond $3?

Last week we have been covering Novan (NOVN) stock heavily, we have found more evidence that Novan may be acquired by Ligand Pharmaceuticals (LGND).

We know Novan has decided to move out, possibly closer to Ligand Pharmaceuticals.

Novan (NOVN) moves out & Kriya Therapeutics moves in

Originally tweeted by watchhillgirl (@watchhillgirl1) on July 26, 2020.

As you can see in the video above, Kriya Therapeutics is now in control of the location. While the company is not currently public they did manage to raise around $80 million back in May for one-time transformitive & advanced gene therapies.

What is Kriya Therapeutics?

Kriya is focused on developing gene therapies for diseases affecting millions of patients, expanding the field of gene therapy beyond rare monogenic disorders. Kriya is targeting diseases where the underlying biology is well-understood, with the goal of rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate human tissues.

The company’s initial pipeline includes multiple programs for the treatment of metabolic diseases including type 1 diabetes, type 2 diabetes, and severe obesity.

What does this mean for Novan (NOVN)?

This further proves that Novan (NOVN) could be gearing up for something huge and whatever it is could fairly push the stock price well above $3 in the event that it is positive news. Novan secured funding over the next 30 months and now they moved. I see this as lowering expenses in an uncertain time and/or gearing up for something, there are lots of possibilities here.

Trump going to Morrisville

According to recent news, Trump will be visiting Morrisville for a tour of FUJIFILM Diosynth Biotechnologies biotech facility for rapid development of vaccines for COVID-19 clinical trial.

After the tour, White House officials say Trump will discuss the collaboration between his administration and the private sector to accelerate the development of a COVID-19 vaccine suitable for human use.

Is Novan (NOVN) a profitable investment?

Shares of Novan (NOVN) appear to be a very good investment option, the Money Midnight Indicator is expecting its price to increase considerably in the next several months. The majority of the metrics point to this investment being highly attractive.

Looking for an easier way to beat the market? Get Money Signals straight to your phone with over 50% in profits! Join now!

Jay Lorrence
Jay Lorrence

Investor of 12 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research.

Articles: 233

Newsletter Updates

Enter your email address below to subscribe to our newsletter